Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dolichyl-phosphate mannosyltransferase subunit 1, catalytic (DPM1), is the catalytic component of the dolichyl-phosphate mannose (DPM) synthase enzyme complex, which is responsible for transferring mannose from GDP-mannose to dolichol monophosphate to produce dolichol-phosphate mannose (Dol-P-Man) on the cytosolic side of the endoplasmic reticulum (ER)[1][5][6]. Dol-P-Man serves as a crucial donor for mannosyl residues in several glycosylation processes, including N-glycosylation, GPI-anchor biosynthesis, and O-mannosylation of proteins. DPM1 is essential for normal cell function and development; genetic deficiencies cause congenital disorders of glycosylation. DPM1 lacks a transmembrane domain and is regulated by additional subunits DPM2 and DPM3 that assist in ER localization and complex stability[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dolichyl-phosphate mannosyltransferase subunit 1, catalytic (DPM1).